Journal of Neurosurgery

Papers
(The H4-Index of Journal of Neurosurgery is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas74
An artificial intelligence framework for automatic segmentation and volumetry of vestibular schwannomas from contrast-enhanced T1-weighted and high-resolution T2-weighted MRI71
Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy66
Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control59
Intraoperative MRI versus 5-ALA in high-grade glioma resection: a network meta-analysis47
Late (5–20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease47
The neurosurgery applicant’s “arms race”: analysis of medical student publication in the Neurosurgery Residency Match47
Effects of clazosentan on cerebral vasospasm–related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients43
Optimal indications and limitations of endoscopic transorbital superior eyelid surgery for spheno-orbital meningiomas42
Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways41
Enhanced Recovery After Surgery strategies for elective craniotomy: a systematic review39
MR-guided focused ultrasound pallidotomy for Parkinson’s disease: safety and feasibility39
The Simpson grade: abandon the scale but preserve the message38
How long is the tail end of the learning curve? Results from 1000 consecutive endoscopic endonasal skull base cases following the initial 200 cases38
Invasive neuromonitoring with an extended definition of delayed cerebral ischemia is associated with improved outcome after poor-grade subarachnoid hemorrhage37
Influence of supramarginal resection on survival outcomes after gross-total resection of IDH–wild-type glioblastoma35
Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia35
Combined and simultaneous endoscopic endonasal and transorbital surgery for a Meckel’s cave schwannoma: technical nuances of a mini-invasive, multiportal approach35
Objective quantification of contrast enhancement of unruptured intracranial aneurysms: a high-resolution vessel wall imaging validation study34
Treatment of chronic subdural hematoma with atorvastatin combined with low-dose dexamethasone: phase II randomized proof-of-concept clinical trial33
Impact of cortical hemodynamic failure on both subsequent hemorrhagic stroke and effect of bypass surgery in hemorrhagic moyamoya disease: a supplementary analysis of the Japan Adult Moyamoya Trial33
Imaging characteristics of adult H3 K27M-mutant gliomas32
Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas31
ChatGPT versus the neurosurgical written boards: a comparative analysis of artificial intelligence/machine learning performance on neurosurgical board–style questions31
Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis30
Hemodynamic analysis of the recipient parasylvian cortical arteries for predicting postoperative hyperperfusion during STA-MCA bypass in adult patients with moyamoya disease29
Biologically effective dose and prediction of obliteration of unruptured arteriovenous malformations treated by upfront Gamma Knife radiosurgery: a series of 149 consecutive cases29
Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders29
Development and clinical validation of a grading system for pituitary adenoma consistency29
0.0621018409729